The use of aflibercept (VEGF trap) in mitigating sulfur mustard-induced corneal neovascularization in a rabbit model

Sulfur mustard (SM)-induced ocular injury is characterized by an acute inflammatory response that may become chronic or enter a latent phase with delayed pathology. This study aimed to evaluate the efficacy of ziv-aflibercept and aflibercept in preventing and ameliorating corneal neovascularization...

Full description

Bibliographic Details
Main Authors: Ariel Gore, Tamar Kadar, Maayan Cohen, Hila Gutman, Rellie Gez, Shlomit Dachir, Vered Horwitz
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Toxicology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214750023000136
_version_ 1797798871935483904
author Ariel Gore
Tamar Kadar
Maayan Cohen
Hila Gutman
Rellie Gez
Shlomit Dachir
Vered Horwitz
author_facet Ariel Gore
Tamar Kadar
Maayan Cohen
Hila Gutman
Rellie Gez
Shlomit Dachir
Vered Horwitz
author_sort Ariel Gore
collection DOAJ
description Sulfur mustard (SM)-induced ocular injury is characterized by an acute inflammatory response that may become chronic or enter a latent phase with delayed pathology. This study aimed to evaluate the efficacy of ziv-aflibercept and aflibercept in preventing and ameliorating corneal neovascularization (NV), respectively, following chemical eye exposure to SM vapor in a rabbit model. Chemical SM ocular insult was induced in the right eye of rabbits. A single application of ziv-aflibercept was administered 2 h or 9 days post-exposure. A single subconjunctival aflibercept treatment in an ocular formulation was administered 4 weeks after SM vapor exposure and subsequent to an initial 1-week treatment with 0.1 % dexamethasone. Clinical monitoring was performed 5–12 weeks post-exposure, and digital corneal pictures were taken to assess the extent of NV. The rabbits were euthanized and the corneas were processed for histological assessment. Treatment with ziv-aflibercept 2 h and 9 days post-exposure moderately reduced insult severity and partially delayed or prevented corneal NV. Aflibercept application 4 weeks post-exposure significantly reduced the extent of NV for 8 weeks. The substantial decrease in existing corneal NV in this group was confirmed by histology. These results reveal the powerful anti-angiogenic efficacy of the VEGF-trap for ameliorating existing NV as opposed to preventing NV development, revealing the ability of this treatment to mitigate corneal NV.
first_indexed 2024-03-13T04:10:58Z
format Article
id doaj.art-5a86abe24db54c258249ac45e0d26573
institution Directory Open Access Journal
issn 2214-7500
language English
last_indexed 2024-03-13T04:10:58Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Toxicology Reports
spelling doaj.art-5a86abe24db54c258249ac45e0d265732023-06-21T06:55:03ZengElsevierToxicology Reports2214-75002023-01-0110206215The use of aflibercept (VEGF trap) in mitigating sulfur mustard-induced corneal neovascularization in a rabbit modelAriel Gore0Tamar Kadar1Maayan Cohen2Hila Gutman3Rellie Gez4Shlomit Dachir5Vered Horwitz6Corresponding author.; Department. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, IsraelDepartment. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, IsraelDepartment. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, IsraelDepartment. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, IsraelDepartment. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, IsraelDepartment. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, IsraelDepartment. of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, IsraelSulfur mustard (SM)-induced ocular injury is characterized by an acute inflammatory response that may become chronic or enter a latent phase with delayed pathology. This study aimed to evaluate the efficacy of ziv-aflibercept and aflibercept in preventing and ameliorating corneal neovascularization (NV), respectively, following chemical eye exposure to SM vapor in a rabbit model. Chemical SM ocular insult was induced in the right eye of rabbits. A single application of ziv-aflibercept was administered 2 h or 9 days post-exposure. A single subconjunctival aflibercept treatment in an ocular formulation was administered 4 weeks after SM vapor exposure and subsequent to an initial 1-week treatment with 0.1 % dexamethasone. Clinical monitoring was performed 5–12 weeks post-exposure, and digital corneal pictures were taken to assess the extent of NV. The rabbits were euthanized and the corneas were processed for histological assessment. Treatment with ziv-aflibercept 2 h and 9 days post-exposure moderately reduced insult severity and partially delayed or prevented corneal NV. Aflibercept application 4 weeks post-exposure significantly reduced the extent of NV for 8 weeks. The substantial decrease in existing corneal NV in this group was confirmed by histology. These results reveal the powerful anti-angiogenic efficacy of the VEGF-trap for ameliorating existing NV as opposed to preventing NV development, revealing the ability of this treatment to mitigate corneal NV.http://www.sciencedirect.com/science/article/pii/S2214750023000136Ocular chemical insultOcular surfaceSulfur mustardNeovascularizationAflibercept
spellingShingle Ariel Gore
Tamar Kadar
Maayan Cohen
Hila Gutman
Rellie Gez
Shlomit Dachir
Vered Horwitz
The use of aflibercept (VEGF trap) in mitigating sulfur mustard-induced corneal neovascularization in a rabbit model
Toxicology Reports
Ocular chemical insult
Ocular surface
Sulfur mustard
Neovascularization
Aflibercept
title The use of aflibercept (VEGF trap) in mitigating sulfur mustard-induced corneal neovascularization in a rabbit model
title_full The use of aflibercept (VEGF trap) in mitigating sulfur mustard-induced corneal neovascularization in a rabbit model
title_fullStr The use of aflibercept (VEGF trap) in mitigating sulfur mustard-induced corneal neovascularization in a rabbit model
title_full_unstemmed The use of aflibercept (VEGF trap) in mitigating sulfur mustard-induced corneal neovascularization in a rabbit model
title_short The use of aflibercept (VEGF trap) in mitigating sulfur mustard-induced corneal neovascularization in a rabbit model
title_sort use of aflibercept vegf trap in mitigating sulfur mustard induced corneal neovascularization in a rabbit model
topic Ocular chemical insult
Ocular surface
Sulfur mustard
Neovascularization
Aflibercept
url http://www.sciencedirect.com/science/article/pii/S2214750023000136
work_keys_str_mv AT arielgore theuseofafliberceptvegftrapinmitigatingsulfurmustardinducedcornealneovascularizationinarabbitmodel
AT tamarkadar theuseofafliberceptvegftrapinmitigatingsulfurmustardinducedcornealneovascularizationinarabbitmodel
AT maayancohen theuseofafliberceptvegftrapinmitigatingsulfurmustardinducedcornealneovascularizationinarabbitmodel
AT hilagutman theuseofafliberceptvegftrapinmitigatingsulfurmustardinducedcornealneovascularizationinarabbitmodel
AT relliegez theuseofafliberceptvegftrapinmitigatingsulfurmustardinducedcornealneovascularizationinarabbitmodel
AT shlomitdachir theuseofafliberceptvegftrapinmitigatingsulfurmustardinducedcornealneovascularizationinarabbitmodel
AT veredhorwitz theuseofafliberceptvegftrapinmitigatingsulfurmustardinducedcornealneovascularizationinarabbitmodel
AT arielgore useofafliberceptvegftrapinmitigatingsulfurmustardinducedcornealneovascularizationinarabbitmodel
AT tamarkadar useofafliberceptvegftrapinmitigatingsulfurmustardinducedcornealneovascularizationinarabbitmodel
AT maayancohen useofafliberceptvegftrapinmitigatingsulfurmustardinducedcornealneovascularizationinarabbitmodel
AT hilagutman useofafliberceptvegftrapinmitigatingsulfurmustardinducedcornealneovascularizationinarabbitmodel
AT relliegez useofafliberceptvegftrapinmitigatingsulfurmustardinducedcornealneovascularizationinarabbitmodel
AT shlomitdachir useofafliberceptvegftrapinmitigatingsulfurmustardinducedcornealneovascularizationinarabbitmodel
AT veredhorwitz useofafliberceptvegftrapinmitigatingsulfurmustardinducedcornealneovascularizationinarabbitmodel